等待开盘 09-16 09:30:00 美东时间
+0.390
+0.50%
BioXcel Therapeutics' CEO, Vimal Mehta, Ph.D., will present a company overview at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 4:30 p.m. ET. The presentation will be available via webcast. BioXcel Therapeutics utilizes AI to develop innovative medicines in neuroscience and immuno-oncology, focusing on drug re-innovation to identify new therapeutic indications. The event webcast and additional information c...
09-04 11:00
Bluelinx Holdings ( ($BXC) ) just unveiled an announcement. On August 27, 2025,...
08-29 05:50
今日重点评级关注:Maxim Group:上调优利系统评级至"买入",目标价9美元;Canaccord Genuity:维持Enovix"买入"评级,目标价从20美元升至22美元
08-05 08:35
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $110 to $83.
08-01 22:41
Bluelinx Holdings ( ($BXC) ) has shared an announcement. On July 29, 2025, Blue...
07-30 04:28
BlueLinx Hldgs (NYSE:BXC) reported quarterly earnings of $0.70 per share which missed the analyst consensus estimate of $1.00 by 30.14 percent. This is a 58.33 percent decrease over earnings of $1.68 per share from the
07-30 04:12
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
BlueLinx Hldgs (NYSE:BXC) will release its quarterly earnings report on Tuesday...
07-29 05:01
DA Davidson analyst Kurt Yinger downgrades BlueLinx Hldgs (NYSE:BXC) from Buy to Neutral and announces $80 price target.
07-18 19:41
Bluelinx Holdings ( ($BXC) ) has provided an announcement. On June 6, 2025, Blu...
06-11 22:28